Steven Cohen Esperion Therapeutics, Inc. Put Options Transaction History

Point72 Asset Management, L.P.

  • $39.3 Billion
  • Q1 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024
BUY
$2.02 - $3.02 $404,000 - $604,000
200,000 New
200,000 $536,000
Q4 2022

Feb 14, 2023
BUY
$5.09 - $8.5 $509,000 - $850,000
100,000 Added 200.0%
150,000 $934,000
Q3 2022

Nov 14, 2022
BUY
$5.45 - $8.13 $272,500 - $406,500
50,000 New
50,000 $335,000

Others Institutions Holding ESPR

# of Institutions
174
Shares Held
125M
Call Options Held
2.08M
Put Options Held
1.01M
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $156M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email